These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20863235)

  • 1. Suppression of hepatitis C virus genome replication in cells with RNA-cleaving DNA enzymes and short-hairpin RNA.
    Lee B; Kim KB; Oh S; Choi JS; Park JS; Min DH; Kim DE
    Oligonucleotides; 2010 Dec; 20(6):285-96. PubMed ID: 20863235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional delivery of DNAzyme with iron oxide nanoparticles for hepatitis C virus gene knockdown.
    Ryoo SR; Jang H; Kim KS; Lee B; Kim KB; Kim YK; Yeo WS; Lee Y; Kim DE; Min DH
    Biomaterials; 2012 Mar; 33(9):2754-61. PubMed ID: 22206595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome.
    Takigawa Y; Nagano-Fujii M; Deng L; Hidajat R; Tanaka M; Mizuta H; Hotta H
    Microbiol Immunol; 2004; 48(8):591-8. PubMed ID: 15322339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication.
    Roy S; Gupta N; Subramanian N; Mondal T; Banerjea AC; Das S
    J Gen Virol; 2008 Jul; 89(Pt 7):1579-1586. PubMed ID: 18559927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of intracellular hepatitis C RNA in the virus core protein coding region by deoxyribozymes.
    Trepanier J; Tanner JE; Momparler RL; Le ON; Alvarez F; Alfieri C
    J Viral Hepat; 2006 Feb; 13(2):131-8. PubMed ID: 16436131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target-site selection for the 10-23 DNAzyme.
    Cairns MJ; Sun LQ
    Methods Mol Biol; 2004; 252():267-77. PubMed ID: 15017056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hepatitis C virus RNA replication by short hairpin RNA synthesized by T7 RNA polymerase in hepatitis C virus subgenomic replicons.
    Hamazaki H; Ujino S; Miyano-Kurosaki N; Shimotohno K; Takaku H
    Biochem Biophys Res Commun; 2006 May; 343(3):988-94. PubMed ID: 16566896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligodeoxyribozymes that cleave beta-catenin messenger RNA inhibit growth of colon cancer cells via reduction of beta-catenin response transcription.
    Choi BR; Gwak J; Kwon HM; Oh S; Kim KP; Choi WH; Cho YH; Kim DE
    Mol Cancer Ther; 2010 Jun; 9(6):1894-902. PubMed ID: 20501807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro-selected RNA cleaving DNA enzymes from a combinatorial library are potent inhibitors of HIV-1 gene expression.
    Sriram B; Banerjea AC
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):667-73. PubMed ID: 11104672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A complex RNA-cleaving DNAzyme that can efficiently cleave a pyrimidine-pyrimidine junction.
    Lam JC; Withers JB; Li Y
    J Mol Biol; 2010 Jul; 400(4):689-701. PubMed ID: 20630470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific cleavage of HCV genomic RNA and its cloned core and NS5B genes by DNAzyme.
    Kumar D; Chaudhury I; Kar P; Das RH
    J Gastroenterol Hepatol; 2009 May; 24(5):872-8. PubMed ID: 19220662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication.
    Ariumi Y; Kuroki M; Abe K; Dansako H; Ikeda M; Wakita T; Kato N
    J Virol; 2007 Dec; 81(24):13922-6. PubMed ID: 17855521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Replication of the subgenomic hepatitis C virus replicon in the presence of the NS3 protease inhibitors: a stochastic model].
    Ivanisenko NV; Mishchenko EL; Akberdin IR; Demenkov PS; Likhoshvai VA; Kozlov KN; Todorov DI; Samsonova MG; Samsonov AM; Kolchanov NA; Ivanisenko VA
    Biofizika; 2013; 58(5):758-74. PubMed ID: 25481944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Replication of hepatitis C virus genome].
    Kato N
    Uirusu; 2008 Dec; 58(2):191-8. PubMed ID: 19374197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
    Kim M; Shin D; Kim SI; Park M
    Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
    McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
    J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and Biosensing Applications of Diverse RNA-Cleaving DNAzymes.
    Liu M; Chang D; Li Y
    Acc Chem Res; 2017 Sep; 50(9):2273-2283. PubMed ID: 28805376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
    Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
    J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA.
    Abe K; Ikeda M; Dansako H; Naka K; Kato N
    Virus Res; 2007 Apr; 125(1):88-97. PubMed ID: 17239465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.